Bern, Berne, Switzerland
Co-Founder & CEO of Aseptuva, a MedTech company on a mission to significantly reduce hospital-acquired infections and prevent avoidable deaths. Every year, millions of patients acquire infections simply by being in a hospital - placing a major burden on patients, nursing staff, and healthcare systems. At Aseptuva, we are developing safe, next-generation UVC-based technology to continuously reduce pathogens in clinical environments, without disrupting workflows or compromising safety. Our ambition is clear: to make hospitals measurably safer, shorten patient stays, reduce mortality, and save billions in healthcare costs - while easing the daily pressure on clinical staff. Aseptuva is supported by experienced healthtech entrepreneurs, investors, and competitive research grants, with clinical guidance from leading experts in infectiology and intensive care medicine. We are preparing for market entry in the US, UK, and Switzerland, with a long-term vision for global impact.
Contributes to the development of safe, next-generation UVC technologies designed to continuously reduce pathogens and combat hospital-acquired infections in clinical environments.
Provided customer support and managed external engagements, complemented by accounting responsibilities, marketing activities, and technical software advisory.
Oversaw the successful planning and execution of a large-scale event with more than 25,000 visitors, coordinating closely with over 30 associations.
Played a major role in initiatives at Schweizer Jugend forscht, including its 50th anniversary in 2017, and co-founded the Alumni Network, where service continues as a board member.
Provided support to Relationship Managers in Wealth Management and acted as a key liaison for Global External Asset Managers.